BACKGROUND: Hepatic and pancreatic surgery is rarely performed in patients with end-stage renal disease (ESRD). The present authors used a national clinical database to characterize outcomes and perioperative risk in ESRD patients who require hepatic or pancreatic resection. METHODS: The 2005-2011 National Surgical Quality Improvement Program database was queried for all patients undergoing hepatic or pancreatic resection. Patients were classified by the presence or absence of ESRD. The independent effects of ESRD on outcomes were assessed after propensity score adjustment and multivariable logistic regression. RESULTS: Of the 27 376 patients submitted to hepatic or pancreatic procedures identified in the database, 101 patients were found to have preoperative ESRD. Patients with ESRD experienced perioperative mortality at a rate similar to that in those without ESRD (5.0% versus 2.3%; P = 0.08). After risk adjustment, the presence of ESRD was associated with three-fold higher odds of postoperative sepsis (adjusted odds ratio: 2.98, P = 0.014), but no significant differences in mortality or major complication rates. CONCLUSIONS: Hepatic and pancreatic resections can be performed safely in selected patients with ESRD. These patients may have an increased risk for the development of postoperative sepsis. Further study is needed to characterize modifiable risk factors that impact outcomes in patients with ESRD who require hepatic or pancreatic resection.
BACKGROUND: Hepatic and pancreatic surgery is rarely performed in patients with end-stage renal disease (ESRD). The present authors used a national clinical database to characterize outcomes and perioperative risk in ESRDpatients who require hepatic or pancreatic resection. METHODS: The 2005-2011 National Surgical Quality Improvement Program database was queried for all patients undergoing hepatic or pancreatic resection. Patients were classified by the presence or absence of ESRD. The independent effects of ESRD on outcomes were assessed after propensity score adjustment and multivariable logistic regression. RESULTS: Of the 27 376 patients submitted to hepatic or pancreatic procedures identified in the database, 101 patients were found to have preoperative ESRD. Patients with ESRD experienced perioperative mortality at a rate similar to that in those without ESRD (5.0% versus 2.3%; P = 0.08). After risk adjustment, the presence of ESRD was associated with three-fold higher odds of postoperative sepsis (adjusted odds ratio: 2.98, P = 0.014), but no significant differences in mortality or major complication rates. CONCLUSIONS: Hepatic and pancreatic resections can be performed safely in selected patients with ESRD. These patients may have an increased risk for the development of postoperative sepsis. Further study is needed to characterize modifiable risk factors that impact outcomes in patients with ESRD who require hepatic or pancreatic resection.
Authors: Sebastien Drolet; Anthony R Maclean; Robert P Myers; Abdel Aziz M Shaheen; Elijah Dixon; W Donald Buie Journal: Dis Colon Rectum Date: 2010-11 Impact factor: 4.585
Authors: Malcolm H Squires; Vishes V Mehta; Sarah B Fisher; Neha L Lad; David A Kooby; Juan M Sarmiento; Kenneth Cardona; Maria C Russell; Charles A Staley; Shishir K Maithel Journal: J Am Coll Surg Date: 2013-11-07 Impact factor: 6.113
Authors: Csaba Gajdos; Mary T Hawn; Deidre Kile; William G Henderson; Thomas Robinson; Martin McCarter; Mark Nehler Journal: Ann Surg Date: 2013-04 Impact factor: 12.969
Authors: Jens Lutz; Julia Menke; Daniel Sollinger; Helmut Schinzel; Klaus Thürmel Journal: Nephrol Dial Transplant Date: 2013-10-16 Impact factor: 5.992
Authors: Dharmenaan Palamuthusingam; Arun Nadarajah; Elaine M Pascoe; Jonathan Craig; David W Johnson; Carmel M Hawley; Magid Fahim Journal: PLoS One Date: 2020-06-26 Impact factor: 3.240